Chugai Pharmaceutical Co. (CHGCY)
(Delayed Data from OTC)
$23.12 USD
+0.11 (0.48%)
Updated Sep 19, 2025 03:59 PM ET
3-Hold of 5 3
C Value B Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Chugai Pharmaceutical Co., Ltd. Unsponsored ADR has a market cap of $75.73B, which represents its share price of $23.01 multiplied by its outstanding shares number of 3.29B. As a large-cap company, CHGCY's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CHGCY 23.12 +0.11(0.48%)
Will CHGCY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CHGCY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHGCY
Are Medical Stocks Lagging AngioDynamics (ANGO) This Year?
Chugai Pharmaceutical Co. (CHGCY) Upgraded to Buy: Here's Why
CHGCY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?
Other News for CHGCY
Eli Lilly upgraded at HSBC after latest trial win for obesity pill
Chugai Pharmaceutical (CHGCY) Sees Stock Surge After Eli Lilly Trial Success
Chugai spikes after Eli Lilly trial win for obesity pill
Market Today: MongoDB (MDB) Surges on Strong Q2 Results
Macquarie Healthcare Fund Q2 2025 Commentary